The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs

Triple-negative breast cancer (TNBC) is a type of breast cancer with lack the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is the most aggressive breast cancer and the most difficult to treat due to its poor response to tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Ziyi Chen, Yi Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1437022/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841527804820193280
author Ziyi Chen
Yi Zhao
Yi Zhao
author_facet Ziyi Chen
Yi Zhao
Yi Zhao
author_sort Ziyi Chen
collection DOAJ
description Triple-negative breast cancer (TNBC) is a type of breast cancer with lack the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is the most aggressive breast cancer and the most difficult to treat due to its poor response to treatments and extremely invasive characteristics. The typical treatment for TNBC frequently results in relapse because of the lack of particular treatment choices. It is urgent to focus on identifying a workable and effective target for the treatment of TNBC. Cancer metastasis is significantly influenced by epithelial-mesenchymal transition (EMT). Ferroptosis is an iron-dependent cell death form, and changes its key factor to affect the proliferation and metastasis of TNBC. Several reports have established associations between EMT and ferroptosis in TNBC metastasis. Furthermore, non-coding RNA (ncRNA), which has been previously described, can also control cancer cell death and metastasis. Thus, in this review, we summarize the correlation and pathways among the ferroptosis, EMT, and ncRNAs in TNBC metastasis. Also, aim to find out a novel strategy for TNBC treatment through the ncRNA-ferroptosis-EMT axis.
format Article
id doaj-art-1abe67d2fd5949f2a8ce16b9c567a435
institution Kabale University
issn 1663-9812
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-1abe67d2fd5949f2a8ce16b9c567a4352025-01-15T06:10:37ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.14370221437022The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAsZiyi Chen0Yi Zhao1Yi Zhao2Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, ChinaInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, ChinaKey Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Healthcare Hospital of Shandong Province Affiliated to Qingdao University, Jinan, Shandong, ChinaTriple-negative breast cancer (TNBC) is a type of breast cancer with lack the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is the most aggressive breast cancer and the most difficult to treat due to its poor response to treatments and extremely invasive characteristics. The typical treatment for TNBC frequently results in relapse because of the lack of particular treatment choices. It is urgent to focus on identifying a workable and effective target for the treatment of TNBC. Cancer metastasis is significantly influenced by epithelial-mesenchymal transition (EMT). Ferroptosis is an iron-dependent cell death form, and changes its key factor to affect the proliferation and metastasis of TNBC. Several reports have established associations between EMT and ferroptosis in TNBC metastasis. Furthermore, non-coding RNA (ncRNA), which has been previously described, can also control cancer cell death and metastasis. Thus, in this review, we summarize the correlation and pathways among the ferroptosis, EMT, and ncRNAs in TNBC metastasis. Also, aim to find out a novel strategy for TNBC treatment through the ncRNA-ferroptosis-EMT axis.https://www.frontiersin.org/articles/10.3389/fphar.2024.1437022/fullferroptosisEMTbreast cancernon-coding RNAmetastasis
spellingShingle Ziyi Chen
Yi Zhao
Yi Zhao
The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
Frontiers in Pharmacology
ferroptosis
EMT
breast cancer
non-coding RNA
metastasis
title The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
title_full The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
title_fullStr The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
title_full_unstemmed The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
title_short The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
title_sort mechanism underlying metastasis in triple negative breast cancer focusing on the interplay between ferroptosis epithelial mesenchymal transition and non coding rnas
topic ferroptosis
EMT
breast cancer
non-coding RNA
metastasis
url https://www.frontiersin.org/articles/10.3389/fphar.2024.1437022/full
work_keys_str_mv AT ziyichen themechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas
AT yizhao themechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas
AT yizhao themechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas
AT ziyichen mechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas
AT yizhao mechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas
AT yizhao mechanismunderlyingmetastasisintriplenegativebreastcancerfocusingontheinterplaybetweenferroptosisepithelialmesenchymaltransitionandnoncodingrnas